SlideShare a Scribd company logo
Click to edit Master title style
Click to edit Master title style
Click to edit Master title style
Click to edit Master title style
Overview
• Vitamin D status, recommendations and
disease prevention
• Aims
• Methods
• Results
• Outcome and signifance
Click to edit Master title style
Click to edit Master title style
Health benefits of vitamin D
• Low 25(OH)D levels linked to
– Osteoporosis and osteopenia
– Cancer
– Diabetes
– Cardiovascular disease
– Autoimmune disease
– Multiple sclerosis
– Respiratory Illness
– Mental Health
Click to edit Master title style
Click to edit Master title style
Optimal serum 25(OH)D
Serum 25(OH)D, nmol/L 15 20 25 28 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145
Adapted from Garland CF, Baggerly CA. www.grassrootshealth.org
Click to edit Master title style
Click to edit Master title style
Vitamin D intake recommendations
*Recommendations based on maintaining serum vitamin D > 75 nmol/L
(30ng/ml)
Recognition that individuals who are obese or on certain medications be
give 2-3 times more vitamin D
40 IU = 1 µg
Age NHMRC IOM US Endo
Society*
0-1 200 400 1000
1-18 200 600 1000
19-49 200 600 1500-2000
50-69 400 600 1500-2000
70 and over 600 800 1500-2000
Click to edit Master title style
Click to edit Master title style
Aims of study
1. Investigate vitamin D status in a large
cohort of individuals residing in NSW
2. Determine the effect of patient setting,
gender, season, remoteness,
socioeconomic status, latitude and
longitude on vitamin D level
Click to edit Master title style
Click to edit Master title style
Adequate vitamin D status
Vitamin D (nmol/L*)
Conventional
guidelines
Newer
recommendations+
Severe Deficiency <12.5
Moderate deficiency 12.5-25
Mild deficiency 25-50 <50
Insufficiency 50-75
Sufficiency >50 >75
*2.5 nmol/L = 1 ng/ml
+Bischoff Ferrari, AJCN 2006
Click to edit Master title style
Click to edit Master title style
Australian Studies
No. of
subjects
Latitude (0S) Mean
25(OH)D
Prevalence (%) Ref.
<28 nmol/L <50 nmol/L
Overall
VIC 861 38 - 7.2 30.0 Pasco 2001
SE QLD 414 28 69.1 8.0 23.4 McGrath 2001
Winter
SE QLD 28 - 40.5 McGrath 2001
VIC 861 38 59.1 11.3 43.2 Pasco 2001
VIC 287 38 17.6 60.3 Pasco 2004
TAS 404 43 36.2 ~7.4 50.7 Van der Mei
2007
QLD/VIC
/TAS
1669 28-43 67.0/75.5/
51.1
7.1/7.9/
13.0
40.5/37.4/
67.3
Van der Mei
2007 b (pooled
analysis)
Click to edit Master title style
Click to edit Master title style
Season and vitamin D status
• Previously assumed enough vitamin D
synthesised and stored for winter requirements
• Half life of vitamin D 1-2 months
• Submariner study showed mean 25(OH)D levels
declined from 78nmol/L to 48 nmol/L in 2 months
in absence of sunlight (P < 0.0001). Diet
included fortified milk and bread
• Other studies show between 40% and 80%
reduction
Dlugos 1995; Veith 1999
Click to edit Master title style
Click to edit Master title style
4697
31131 25(OH)D assays
1 July 2008 and 30 July 2010
Primary test, complete data
available for gender, age, patient
setting, date of test, postcode**,
known breast cancer case,
25(OH)D ≤400 nmol/L
Sample type
10839 13979
Diagnostic referral
Outpatient
Private outpatient
Emergency
Inpatient
Private hospital
patient
Public hospital
patient
Private patient
29516
24819
Yes
680618012
Female Male
62016251
Summer Winter
61216245
Autumn Spring
1615
QC sample
Research
Miscellaneous
Unknown
* *Matched
to ARIA,
SEIFA,
Latitude,
Longitude
Click to edit Master title style
Click to edit Master title style
Demographics
Patient setting No. (%)
Outpatient 13979 (56.3)
Inpatient 10839 (43.7)
Gender
Female 18012 (72.5)
Male 6806 (27.4)
Season
Summer 6251 (25.2)
Autumn 6245(25.2)
Winter 6201 (25.0)
Spring 6121 (24.7)
Rural and
remoteness index
No. (%)
Major city 16101 (67.3)
Inner regional 3363 (14.1)
Outer regional 3730 (15.6)
Remote 446 (1.9)
Very remote 281 (1.2)
IRSD*
Quintile 1 7507 (31.4)
Quintile 2 4659 (19.9)
Quintile 3 6152 (27.2)
Quintile 4 1944 (8.1)
Quintile 5 3296 (13.8)
*Index of relative socioeconomic disadvantage
Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by gender
74.0
45.1
65.5
43.2
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
Male
Female
45%
reduction
by June
P<.001
37%
reduction
by June
Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by patient setting
70.2
44.9
63.4
42.9
40.0
45.0
50.0
55.0
60.0
65.0
70.0
Ambulatory
subject
Inpatient
P<.001
Click to edit Master title style
Click to edit Master title style
79.1
48.6
60.4
42.6
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
80.0
Ambulatory Male
Ambulatory Female
Inpatient Male
Inpatient Female
Supporting Women with Breast
Cancer Today and Every Day
Mean 25(OH)D by gender and
patient setting
Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by age group
*77.0
65.6
40.7
*61.2
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
80.0
<20
20-39
40-59
60-79
≥80
*P<.001
Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by remoteness
0
10
20
30
40
50
60
70
80
Major
cities
Inner
Regional
Outer
Regional
Remote
Australia
Very
Remote
Australia
*66
50
*71
Ambulatory Male
Ambulatory Female
Inpatient male
Inpatient Female
*P<.05
Click to edit Master title style
Click to edit Master title style
Vitamin D status
by gender and season
9%
26%
34%
31%
Female Summer
7%
21%
32%
40%
Male Summer
18%
37%
27%
18%
Male Spring
55
%
21%
37%
27%
15%
Female Spring
Severely Deficient
Deficient
Insufficient
Sufficient
58
%
35
%
28
%
Click to edit Master title style
Click to edit Master title style
18%
36%
30%
16%
Ambulatory subject Spring
12%
27%
31%
30%
Inpatients Summer
23%
39%
24%
14%
Inpatients Spring
Vitamin D status
by patient setting by season
6%
22%
36%
36%
Ambulatory subject Summer
Severely Deficient
Deficient
Insufficient
Sufficient
54
%
62
%
39
%
28
%
Click to edit Master title style
Click to edit Master title style
Vitamin D status for
females from a major city by age
group in spring
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficiency
Deficient Insufficient Sufficient
Ambulatory Subject
Deficient
Severely
Deficiency
Deficient Insufficient Sufficient
Inpatient
20-29 years 30-49 years 80 years and over
68.8%62.5%
Deficient
Click to edit Master title style
Click to edit Master title style
Vitamin D status in
ambulatory females by
socioeconomic status (IRSD)
*Index of relative socioeconomic disadvantage
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficient
Deficient Insufficient Sufficient
Summer
IRSD 1,2
IRSD 9,10
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficient
Deficient Insufficient Sufficient
Spring
38.6 vs 21.2
63.0 vs 51.8
Click to edit Master title style
Click to edit Master title style
Regression Model
• Serum 25(OH)D controlled for gender, patient
setting, season, age category, remoteness from
capital city, socioeconomic disadvantage.
• Overall regression model explained 31.8% of the
variance (p<0.001)
• Models stratified by gender and patient setting
explained between 26.3 (inpatient females and
33.1% (ambulatory females) of variance
• No effect of latitude or longitude
Click to edit Master title style
Click to edit Master title style
Regression model (overall)
 95% CI
Inpatient -7.1 -8.0-(-6.3)
Female -3.9 -4.7-(-3.1)
Season
Summer 15.6 14.6-16.6
Autumn 13.9 13.0-15.0
Winter 3.8 2.8-4.9
Age category
<20 7.7 6.1-9.3
40-59 3.0 1.8-4.2
60-79 2.7 1.6-3.8
≥80 1.3 0.1-2.5
ARIA  95% CI
Inner regional 5.2 4.0-6.3
Outer regional 8.8 7.4-10.2
Remote 13.1 8.8-17.5
Very remote 17.4 13.3-21.6
IRSD
3,4 5.9 4.7-7.2
5,6 4.8 3.8-5.8
7,8 5.1 3.6-6.6
9,10 7.9 6.6-9.1
*all P<.001
Click to edit Master title style
Click to edit Master title style
Strengths & Limitations
• Size of study, diverse population, ability to
control for month of blood draw, age,
ARIA, IRSD, latitude and longitude
• Non-random sample, inability to control for
other factors that effect vitamin D such as
skin pigmentation, body weight, sunlight
exposure, sun protection habits
Click to edit Master title style
Click to edit Master title style
Conclusion
• High prevalence of deficiency in all seasons
but highest in spring
• There is a marked seasonal reduction that
continues into spring
• Particular groups are more at risk of vitamin D
deficiency – young women residing in major
city from lower SES
• Protective factors include living in rural areas,
being male and from a higher SES
Click to edit Master title style
Click to edit Master title style
Health Implications
• Public health messages required to address
high prevalence of vitamin D deficiency
• Australians are not adequately
supplementing - suitable guidelines are
required
• Implications regarding frequency and timing
of testing
Click to edit Master title style
Click to edit Master title style
Acknowledgements
Westmead Breast Cancer Institute Vitamin D Research Group
John Boyages, (Supervisor, Oncologist, BCI)
Steven Boyages (Supervisor, Endocrinologist, CETI)
Colin Dunstan (Animal Biologist, ANZAC)
Rebecca Mason (Physiologist, Sydney University)
Peter Talbot (Dietitian, Westmead Hospital)
Elisabeth Black (Director of Research, BCI)
Institute of Clinical Pathology and Medical Research
Gary Ma (ICPMR)
Table 1. Mean plasma 25(OH)D levels and baseline characteristics for cases and controls.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
Table 2. Results of the conditional logistic regression analysis including covariates.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
Figure 1. Plot of the computed odds ratios (OR) for the 8 octiles of 25(OH)D concentration, locating
each at the mid-point of the respective octiles.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
Figure 2. Plot of the odds ratio for suicide for the top seven octiles, relative to the lowest octile.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
The subjects with serum concentrations of 25-hydroxyvitamin D [25(OH)D] < 40 nmol/L (n =
24) had significantly (P = 0.004) more days of absence from duty due to respiratory infections
(median: 4; quartile 1–quartile 3: 2–6) than did controls (2; 0–4; incide...
Laaksi I et al. Am J Clin Nutr 2007;86:714-717
©2007 by American Society for Nutrition

More Related Content

Similar to To D or not to D that is the question? Vitamin D deficiency in Australia

Vitamin D: to D or not to D?
Vitamin D: to D or not to D?Vitamin D: to D or not to D?
Vitamin D: to D or not to D?
HealthXn
 
Vitamin D status in children with type 1 diabetes mellitus
Vitamin D status in children with type 1 diabetes mellitusVitamin D status in children with type 1 diabetes mellitus
Vitamin D status in children with type 1 diabetes mellitus
Azad Haleem
 
introduction to molecular biology of diseases.ppt
introduction to molecular biology of diseases.pptintroduction to molecular biology of diseases.ppt
introduction to molecular biology of diseases.ppt
YinebebMezgebu4
 
Clinical management of elderly people with diabetes
Clinical management of elderly people with diabetesClinical management of elderly people with diabetes
Clinical management of elderly people with diabetes
Primary Care Diabetes Europe
 
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
Mikołaj Kamiński
 
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
ueda2015
 
MULTIPLE MYELOMA : RAVI VIJ
MULTIPLE MYELOMA : RAVI VIJMULTIPLE MYELOMA : RAVI VIJ
MULTIPLE MYELOMA : RAVI VIJ
spa718
 
Vitamin D and Bone Health
Vitamin D and Bone HealthVitamin D and Bone Health
Vitamin D and Bone Health
demiss
 
Heaney vit d deficiency
Heaney vit d deficiencyHeaney vit d deficiency
Heaney vit d deficiency
JA Larson
 
Vitamin D in New Zealand
Vitamin D in New ZealandVitamin D in New Zealand
Vitamin D in New Zealand
Gastrodiet
 
Recent advances in mds
Recent advances in mdsRecent advances in mds
Recent advances in mds
madurai
 
Recent advances in mds
Recent advances in mdsRecent advances in mds
Recent advances in mds
madurai
 
The Many Faces of Hyperparathyroidism & Advances in Treatment
The Many Faces of Hyperparathyroidism & Advances in TreatmentThe Many Faces of Hyperparathyroidism & Advances in Treatment
The Many Faces of Hyperparathyroidism & Advances in Treatment
Babak Larian
 
contraversies in totalvitamindassay
contraversies in totalvitamindassaycontraversies in totalvitamindassay
contraversies in totalvitamindassay
dr salwa alrefaee
 
Lipid Targets.ppt
Lipid Targets.pptLipid Targets.ppt
Lipid Targets.ppt
MirkoBotica
 
Serum Vitamin D Deficiency is Associated with NASH in Adults
Serum Vitamin D Deficiency is Associated with NASH in AdultsSerum Vitamin D Deficiency is Associated with NASH in Adults
Serum Vitamin D Deficiency is Associated with NASH in Adults
James Nelson
 
Vieth Vitamin D Status
Vieth Vitamin D StatusVieth Vitamin D Status
Vieth Vitamin D Status
JA Larson
 
vitdospi-091024063028-phpapp01.pptx
vitdospi-091024063028-phpapp01.pptxvitdospi-091024063028-phpapp01.pptx
vitdospi-091024063028-phpapp01.pptx
sandeepsharma637519
 
Controversies in vitamin d therapy
Controversies in vitamin d therapyControversies in vitamin d therapy
Controversies in vitamin d therapy
Nemencio Jr
 
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaDyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
alaa wafa
 

Similar to To D or not to D that is the question? Vitamin D deficiency in Australia (20)

Vitamin D: to D or not to D?
Vitamin D: to D or not to D?Vitamin D: to D or not to D?
Vitamin D: to D or not to D?
 
Vitamin D status in children with type 1 diabetes mellitus
Vitamin D status in children with type 1 diabetes mellitusVitamin D status in children with type 1 diabetes mellitus
Vitamin D status in children with type 1 diabetes mellitus
 
introduction to molecular biology of diseases.ppt
introduction to molecular biology of diseases.pptintroduction to molecular biology of diseases.ppt
introduction to molecular biology of diseases.ppt
 
Clinical management of elderly people with diabetes
Clinical management of elderly people with diabetesClinical management of elderly people with diabetes
Clinical management of elderly people with diabetes
 
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...
 
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
 
MULTIPLE MYELOMA : RAVI VIJ
MULTIPLE MYELOMA : RAVI VIJMULTIPLE MYELOMA : RAVI VIJ
MULTIPLE MYELOMA : RAVI VIJ
 
Vitamin D and Bone Health
Vitamin D and Bone HealthVitamin D and Bone Health
Vitamin D and Bone Health
 
Heaney vit d deficiency
Heaney vit d deficiencyHeaney vit d deficiency
Heaney vit d deficiency
 
Vitamin D in New Zealand
Vitamin D in New ZealandVitamin D in New Zealand
Vitamin D in New Zealand
 
Recent advances in mds
Recent advances in mdsRecent advances in mds
Recent advances in mds
 
Recent advances in mds
Recent advances in mdsRecent advances in mds
Recent advances in mds
 
The Many Faces of Hyperparathyroidism & Advances in Treatment
The Many Faces of Hyperparathyroidism & Advances in TreatmentThe Many Faces of Hyperparathyroidism & Advances in Treatment
The Many Faces of Hyperparathyroidism & Advances in Treatment
 
contraversies in totalvitamindassay
contraversies in totalvitamindassaycontraversies in totalvitamindassay
contraversies in totalvitamindassay
 
Lipid Targets.ppt
Lipid Targets.pptLipid Targets.ppt
Lipid Targets.ppt
 
Serum Vitamin D Deficiency is Associated with NASH in Adults
Serum Vitamin D Deficiency is Associated with NASH in AdultsSerum Vitamin D Deficiency is Associated with NASH in Adults
Serum Vitamin D Deficiency is Associated with NASH in Adults
 
Vieth Vitamin D Status
Vieth Vitamin D StatusVieth Vitamin D Status
Vieth Vitamin D Status
 
vitdospi-091024063028-phpapp01.pptx
vitdospi-091024063028-phpapp01.pptxvitdospi-091024063028-phpapp01.pptx
vitdospi-091024063028-phpapp01.pptx
 
Controversies in vitamin d therapy
Controversies in vitamin d therapyControversies in vitamin d therapy
Controversies in vitamin d therapy
 
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaDyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
 

More from HealthXn

Diabetes therapies and technology: implications for doctors and patients
Diabetes therapies and technology: implications for doctors and patientsDiabetes therapies and technology: implications for doctors and patients
Diabetes therapies and technology: implications for doctors and patients
HealthXn
 
The future interface of mental health with information technology: high touch...
The future interface of mental health with information technology: high touch...The future interface of mental health with information technology: high touch...
The future interface of mental health with information technology: high touch...
HealthXn
 
Preventing diabetes and obesity in mental health disorders
Preventing diabetes and obesity in mental health disordersPreventing diabetes and obesity in mental health disorders
Preventing diabetes and obesity in mental health disorders
HealthXn
 
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
HealthXn
 
How to prevent Deep Vein Thrombosis when travelling
How to prevent Deep Vein Thrombosis when travellingHow to prevent Deep Vein Thrombosis when travelling
How to prevent Deep Vein Thrombosis when travelling
HealthXn
 
The value of health information systems and EMR to patient care
The value of health information systems and EMR to patient careThe value of health information systems and EMR to patient care
The value of health information systems and EMR to patient care
HealthXn
 
Advances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid diseaseAdvances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid disease
HealthXn
 
Bridging health care’s innovation education gap
Bridging health care’s innovation education gapBridging health care’s innovation education gap
Bridging health care’s innovation education gap
HealthXn
 
Beyond the medical curve presentation
Beyond the medical curve presentationBeyond the medical curve presentation
Beyond the medical curve presentation
HealthXn
 
Prevention against micronutrient malnutrition
Prevention against micronutrient malnutritionPrevention against micronutrient malnutrition
Prevention against micronutrient malnutrition
HealthXn
 
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
HealthXn
 
Thyroid hormone and the brain: understanding the effects of iodine deficiency...
Thyroid hormone and the brain: understanding the effects of iodine deficiency...Thyroid hormone and the brain: understanding the effects of iodine deficiency...
Thyroid hormone and the brain: understanding the effects of iodine deficiency...
HealthXn
 
Optimum Healthcare IT A physician’s perspective on Big Data, Predictive Analy...
Optimum Healthcare ITA physician’s perspective on Big Data, Predictive Analy...Optimum Healthcare ITA physician’s perspective on Big Data, Predictive Analy...
Optimum Healthcare IT A physician’s perspective on Big Data, Predictive Analy...
HealthXn
 
Recent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancerRecent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancer
HealthXn
 
Value creation in health:investing in people and process
Value creation in health:investing in people and processValue creation in health:investing in people and process
Value creation in health:investing in people and process
HealthXn
 
Performance Management in Health: the role of Health IT
Performance Management in Health: the role of Health ITPerformance Management in Health: the role of Health IT
Performance Management in Health: the role of Health IT
HealthXn
 
Bottom up approach required for the adoption of
Bottom up approach required for the adoption ofBottom up approach required for the adoption of
Bottom up approach required for the adoption of
HealthXn
 
The big data challenge in healthcare and how can business intelligence best d...
The big data challenge in healthcare and how can business intelligence best d...The big data challenge in healthcare and how can business intelligence best d...
The big data challenge in healthcare and how can business intelligence best d...
HealthXn
 
Apps 4 health
Apps 4 healthApps 4 health
Apps 4 health
HealthXn
 
4th annual innovation healthcare asia summit panel discussion
4th annual innovation healthcare asia summit panel discussion4th annual innovation healthcare asia summit panel discussion
4th annual innovation healthcare asia summit panel discussion
HealthXn
 

More from HealthXn (20)

Diabetes therapies and technology: implications for doctors and patients
Diabetes therapies and technology: implications for doctors and patientsDiabetes therapies and technology: implications for doctors and patients
Diabetes therapies and technology: implications for doctors and patients
 
The future interface of mental health with information technology: high touch...
The future interface of mental health with information technology: high touch...The future interface of mental health with information technology: high touch...
The future interface of mental health with information technology: high touch...
 
Preventing diabetes and obesity in mental health disorders
Preventing diabetes and obesity in mental health disordersPreventing diabetes and obesity in mental health disorders
Preventing diabetes and obesity in mental health disorders
 
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...
 
How to prevent Deep Vein Thrombosis when travelling
How to prevent Deep Vein Thrombosis when travellingHow to prevent Deep Vein Thrombosis when travelling
How to prevent Deep Vein Thrombosis when travelling
 
The value of health information systems and EMR to patient care
The value of health information systems and EMR to patient careThe value of health information systems and EMR to patient care
The value of health information systems and EMR to patient care
 
Advances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid diseaseAdvances in the diagnosis and treatment for benign and malignant thyroid disease
Advances in the diagnosis and treatment for benign and malignant thyroid disease
 
Bridging health care’s innovation education gap
Bridging health care’s innovation education gapBridging health care’s innovation education gap
Bridging health care’s innovation education gap
 
Beyond the medical curve presentation
Beyond the medical curve presentationBeyond the medical curve presentation
Beyond the medical curve presentation
 
Prevention against micronutrient malnutrition
Prevention against micronutrient malnutritionPrevention against micronutrient malnutrition
Prevention against micronutrient malnutrition
 
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...
 
Thyroid hormone and the brain: understanding the effects of iodine deficiency...
Thyroid hormone and the brain: understanding the effects of iodine deficiency...Thyroid hormone and the brain: understanding the effects of iodine deficiency...
Thyroid hormone and the brain: understanding the effects of iodine deficiency...
 
Optimum Healthcare IT A physician’s perspective on Big Data, Predictive Analy...
Optimum Healthcare ITA physician’s perspective on Big Data, Predictive Analy...Optimum Healthcare ITA physician’s perspective on Big Data, Predictive Analy...
Optimum Healthcare IT A physician’s perspective on Big Data, Predictive Analy...
 
Recent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancerRecent advances in the diagnosis and treatment of thyroid cancer
Recent advances in the diagnosis and treatment of thyroid cancer
 
Value creation in health:investing in people and process
Value creation in health:investing in people and processValue creation in health:investing in people and process
Value creation in health:investing in people and process
 
Performance Management in Health: the role of Health IT
Performance Management in Health: the role of Health ITPerformance Management in Health: the role of Health IT
Performance Management in Health: the role of Health IT
 
Bottom up approach required for the adoption of
Bottom up approach required for the adoption ofBottom up approach required for the adoption of
Bottom up approach required for the adoption of
 
The big data challenge in healthcare and how can business intelligence best d...
The big data challenge in healthcare and how can business intelligence best d...The big data challenge in healthcare and how can business intelligence best d...
The big data challenge in healthcare and how can business intelligence best d...
 
Apps 4 health
Apps 4 healthApps 4 health
Apps 4 health
 
4th annual innovation healthcare asia summit panel discussion
4th annual innovation healthcare asia summit panel discussion4th annual innovation healthcare asia summit panel discussion
4th annual innovation healthcare asia summit panel discussion
 

Recently uploaded

Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 

Recently uploaded (20)

Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 

To D or not to D that is the question? Vitamin D deficiency in Australia

  • 1. Click to edit Master title style Click to edit Master title style
  • 2. Click to edit Master title style Click to edit Master title style Overview • Vitamin D status, recommendations and disease prevention • Aims • Methods • Results • Outcome and signifance
  • 3. Click to edit Master title style Click to edit Master title style Health benefits of vitamin D • Low 25(OH)D levels linked to – Osteoporosis and osteopenia – Cancer – Diabetes – Cardiovascular disease – Autoimmune disease – Multiple sclerosis – Respiratory Illness – Mental Health
  • 4. Click to edit Master title style Click to edit Master title style Optimal serum 25(OH)D Serum 25(OH)D, nmol/L 15 20 25 28 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 Adapted from Garland CF, Baggerly CA. www.grassrootshealth.org
  • 5. Click to edit Master title style Click to edit Master title style Vitamin D intake recommendations *Recommendations based on maintaining serum vitamin D > 75 nmol/L (30ng/ml) Recognition that individuals who are obese or on certain medications be give 2-3 times more vitamin D 40 IU = 1 µg Age NHMRC IOM US Endo Society* 0-1 200 400 1000 1-18 200 600 1000 19-49 200 600 1500-2000 50-69 400 600 1500-2000 70 and over 600 800 1500-2000
  • 6. Click to edit Master title style Click to edit Master title style Aims of study 1. Investigate vitamin D status in a large cohort of individuals residing in NSW 2. Determine the effect of patient setting, gender, season, remoteness, socioeconomic status, latitude and longitude on vitamin D level
  • 7. Click to edit Master title style Click to edit Master title style Adequate vitamin D status Vitamin D (nmol/L*) Conventional guidelines Newer recommendations+ Severe Deficiency <12.5 Moderate deficiency 12.5-25 Mild deficiency 25-50 <50 Insufficiency 50-75 Sufficiency >50 >75 *2.5 nmol/L = 1 ng/ml +Bischoff Ferrari, AJCN 2006
  • 8. Click to edit Master title style Click to edit Master title style Australian Studies No. of subjects Latitude (0S) Mean 25(OH)D Prevalence (%) Ref. <28 nmol/L <50 nmol/L Overall VIC 861 38 - 7.2 30.0 Pasco 2001 SE QLD 414 28 69.1 8.0 23.4 McGrath 2001 Winter SE QLD 28 - 40.5 McGrath 2001 VIC 861 38 59.1 11.3 43.2 Pasco 2001 VIC 287 38 17.6 60.3 Pasco 2004 TAS 404 43 36.2 ~7.4 50.7 Van der Mei 2007 QLD/VIC /TAS 1669 28-43 67.0/75.5/ 51.1 7.1/7.9/ 13.0 40.5/37.4/ 67.3 Van der Mei 2007 b (pooled analysis)
  • 9. Click to edit Master title style Click to edit Master title style Season and vitamin D status • Previously assumed enough vitamin D synthesised and stored for winter requirements • Half life of vitamin D 1-2 months • Submariner study showed mean 25(OH)D levels declined from 78nmol/L to 48 nmol/L in 2 months in absence of sunlight (P < 0.0001). Diet included fortified milk and bread • Other studies show between 40% and 80% reduction Dlugos 1995; Veith 1999
  • 10. Click to edit Master title style Click to edit Master title style 4697 31131 25(OH)D assays 1 July 2008 and 30 July 2010 Primary test, complete data available for gender, age, patient setting, date of test, postcode**, known breast cancer case, 25(OH)D ≤400 nmol/L Sample type 10839 13979 Diagnostic referral Outpatient Private outpatient Emergency Inpatient Private hospital patient Public hospital patient Private patient 29516 24819 Yes 680618012 Female Male 62016251 Summer Winter 61216245 Autumn Spring 1615 QC sample Research Miscellaneous Unknown * *Matched to ARIA, SEIFA, Latitude, Longitude
  • 11. Click to edit Master title style Click to edit Master title style Demographics Patient setting No. (%) Outpatient 13979 (56.3) Inpatient 10839 (43.7) Gender Female 18012 (72.5) Male 6806 (27.4) Season Summer 6251 (25.2) Autumn 6245(25.2) Winter 6201 (25.0) Spring 6121 (24.7) Rural and remoteness index No. (%) Major city 16101 (67.3) Inner regional 3363 (14.1) Outer regional 3730 (15.6) Remote 446 (1.9) Very remote 281 (1.2) IRSD* Quintile 1 7507 (31.4) Quintile 2 4659 (19.9) Quintile 3 6152 (27.2) Quintile 4 1944 (8.1) Quintile 5 3296 (13.8) *Index of relative socioeconomic disadvantage
  • 12. Click to edit Master title style Click to edit Master title style Mean 25(OH)D by gender 74.0 45.1 65.5 43.2 40.0 45.0 50.0 55.0 60.0 65.0 70.0 75.0 Male Female 45% reduction by June P<.001 37% reduction by June
  • 13. Click to edit Master title style Click to edit Master title style Mean 25(OH)D by patient setting 70.2 44.9 63.4 42.9 40.0 45.0 50.0 55.0 60.0 65.0 70.0 Ambulatory subject Inpatient P<.001
  • 14. Click to edit Master title style Click to edit Master title style 79.1 48.6 60.4 42.6 40.0 45.0 50.0 55.0 60.0 65.0 70.0 75.0 80.0 Ambulatory Male Ambulatory Female Inpatient Male Inpatient Female Supporting Women with Breast Cancer Today and Every Day Mean 25(OH)D by gender and patient setting
  • 15. Click to edit Master title style Click to edit Master title style Mean 25(OH)D by age group *77.0 65.6 40.7 *61.2 40.0 45.0 50.0 55.0 60.0 65.0 70.0 75.0 80.0 <20 20-39 40-59 60-79 ≥80 *P<.001
  • 16. Click to edit Master title style Click to edit Master title style Mean 25(OH)D by remoteness 0 10 20 30 40 50 60 70 80 Major cities Inner Regional Outer Regional Remote Australia Very Remote Australia *66 50 *71 Ambulatory Male Ambulatory Female Inpatient male Inpatient Female *P<.05
  • 17. Click to edit Master title style Click to edit Master title style Vitamin D status by gender and season 9% 26% 34% 31% Female Summer 7% 21% 32% 40% Male Summer 18% 37% 27% 18% Male Spring 55 % 21% 37% 27% 15% Female Spring Severely Deficient Deficient Insufficient Sufficient 58 % 35 % 28 %
  • 18. Click to edit Master title style Click to edit Master title style 18% 36% 30% 16% Ambulatory subject Spring 12% 27% 31% 30% Inpatients Summer 23% 39% 24% 14% Inpatients Spring Vitamin D status by patient setting by season 6% 22% 36% 36% Ambulatory subject Summer Severely Deficient Deficient Insufficient Sufficient 54 % 62 % 39 % 28 %
  • 19. Click to edit Master title style Click to edit Master title style Vitamin D status for females from a major city by age group in spring 0% 5% 10% 15% 20% 25% 30% 35% 40% Severely Deficiency Deficient Insufficient Sufficient Ambulatory Subject Deficient Severely Deficiency Deficient Insufficient Sufficient Inpatient 20-29 years 30-49 years 80 years and over 68.8%62.5% Deficient
  • 20. Click to edit Master title style Click to edit Master title style Vitamin D status in ambulatory females by socioeconomic status (IRSD) *Index of relative socioeconomic disadvantage 0% 5% 10% 15% 20% 25% 30% 35% 40% Severely Deficient Deficient Insufficient Sufficient Summer IRSD 1,2 IRSD 9,10 0% 5% 10% 15% 20% 25% 30% 35% 40% Severely Deficient Deficient Insufficient Sufficient Spring 38.6 vs 21.2 63.0 vs 51.8
  • 21. Click to edit Master title style Click to edit Master title style Regression Model • Serum 25(OH)D controlled for gender, patient setting, season, age category, remoteness from capital city, socioeconomic disadvantage. • Overall regression model explained 31.8% of the variance (p<0.001) • Models stratified by gender and patient setting explained between 26.3 (inpatient females and 33.1% (ambulatory females) of variance • No effect of latitude or longitude
  • 22. Click to edit Master title style Click to edit Master title style Regression model (overall)  95% CI Inpatient -7.1 -8.0-(-6.3) Female -3.9 -4.7-(-3.1) Season Summer 15.6 14.6-16.6 Autumn 13.9 13.0-15.0 Winter 3.8 2.8-4.9 Age category <20 7.7 6.1-9.3 40-59 3.0 1.8-4.2 60-79 2.7 1.6-3.8 ≥80 1.3 0.1-2.5 ARIA  95% CI Inner regional 5.2 4.0-6.3 Outer regional 8.8 7.4-10.2 Remote 13.1 8.8-17.5 Very remote 17.4 13.3-21.6 IRSD 3,4 5.9 4.7-7.2 5,6 4.8 3.8-5.8 7,8 5.1 3.6-6.6 9,10 7.9 6.6-9.1 *all P<.001
  • 23. Click to edit Master title style Click to edit Master title style Strengths & Limitations • Size of study, diverse population, ability to control for month of blood draw, age, ARIA, IRSD, latitude and longitude • Non-random sample, inability to control for other factors that effect vitamin D such as skin pigmentation, body weight, sunlight exposure, sun protection habits
  • 24. Click to edit Master title style Click to edit Master title style Conclusion • High prevalence of deficiency in all seasons but highest in spring • There is a marked seasonal reduction that continues into spring • Particular groups are more at risk of vitamin D deficiency – young women residing in major city from lower SES • Protective factors include living in rural areas, being male and from a higher SES
  • 25. Click to edit Master title style Click to edit Master title style Health Implications • Public health messages required to address high prevalence of vitamin D deficiency • Australians are not adequately supplementing - suitable guidelines are required • Implications regarding frequency and timing of testing
  • 26. Click to edit Master title style Click to edit Master title style Acknowledgements Westmead Breast Cancer Institute Vitamin D Research Group John Boyages, (Supervisor, Oncologist, BCI) Steven Boyages (Supervisor, Endocrinologist, CETI) Colin Dunstan (Animal Biologist, ANZAC) Rebecca Mason (Physiologist, Sydney University) Peter Talbot (Dietitian, Westmead Hospital) Elisabeth Black (Director of Research, BCI) Institute of Clinical Pathology and Medical Research Gary Ma (ICPMR)
  • 27. Table 1. Mean plasma 25(OH)D levels and baseline characteristics for cases and controls. Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
  • 28. Table 2. Results of the conditional logistic regression analysis including covariates. Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
  • 29. Figure 1. Plot of the computed odds ratios (OR) for the 8 octiles of 25(OH)D concentration, locating each at the mid-point of the respective octiles. Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
  • 30. Figure 2. Plot of the odds ratio for suicide for the top seven octiles, relative to the lowest octile. Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
  • 31.
  • 32. The subjects with serum concentrations of 25-hydroxyvitamin D [25(OH)D] < 40 nmol/L (n = 24) had significantly (P = 0.004) more days of absence from duty due to respiratory infections (median: 4; quartile 1–quartile 3: 2–6) than did controls (2; 0–4; incide... Laaksi I et al. Am J Clin Nutr 2007;86:714-717 ©2007 by American Society for Nutrition

Editor's Notes

  1. As part of a more specific study we are conducting to understand the relationship between vitamin D status and factors associated with breast cancer prognosis we wanted to assess vitamin D status in the a large population of individuals in and examine the relationship between vitamin D and other environmental factors. Australian studies to date have been limited. Most have sample sizes or examine vitamin D status in individuals at high risk of deficiency.
  2. All percentages reference a common baseline of 60 nmol/L as shown on the chart. %’s reflect the disease prevention % at the beginning and ending of available data. Example: Breast cancer incidence is reduced by 30% when the serum level is 85 nmol/L vs the baseline of 65 nmol/ml. There is an 83% reduction in incidence when the serum level is 125 nmol/L vs the baseline of 25 ng/ml. The x’s in the bars indicate ‘reasonable extrapolations’ from the data but are beyond existing data. All Cancers: Lappe JM, et al. Am J Clin Nutr. 2007;85:1586-91. Breast: Garland CF, Gorham ED, Mohr SB, Grant WB, Garland FC. Breast cancer risk according to serum 25-Hydroxyvitamin D: Meta-analysis of Dose-Response (abstract).American Association for Cancer Research Annual Meeting, 2008. Reference serum 25(OH)D was 5 ng/ml. Garland, CF, et al. Amer Assoc Cancer Research Annual Mtg, April 2008,. Colon: Gorham ED, et al. Am J Prev Med. 2007;32:210-6. Diabetes: Hyppönen E, et al. Lancet 2001;358:1500-3. Endometrium: Mohr SB, et al. Prev Med. 2007;45:323-4. Falls: Broe KE, et al. J Am Geriatr Soc. 2007;55:234-9. Fractures: Bischoff-Ferrari HA, et al. JAMA. 2005;293:2257-64. Heart Attack: Giovannucci et al. Arch Intern Med/Vol 168 (No 11) June 9, 2008. Multiple Sclerosis: Munger KL, et al. JAMA. 2006;296:2832-8. Non-Hodgkin’s Lymphoma: Purdue MP, et al. Cancer Causes Control. 2007;18:989-99. Ovary: Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2007;16:783-8. Renal: Mohr SB, et al. Int J Cancer. 2006;119:2705-9. Rickets: Arnaud SB
  3. Based on adequate sunlight exposure Developed for maintenance of calcium homeostasis and prevention of osteoporosis Call for new recommendations based on newly discovered actions
  4. As part of a more specific study we are conducting to understand the relationship between vitamin D status and factors associated with breast cancer prognosis we wanted to assess vitamin D status in the a large population of individuals in and examine the relationship between vitamin D and other environmental factors. Australian studies to date have been limited. Most have sample sizes or examine vitamin D status in individuals at high risk of deficiency.
  5. Limited information on prevalence of Vit D deficiency in Australians, most studies have been in high risk groups
  6. Current recommendations generally focus on bone health in older people. Evidence suggests that vitamin D intakes above current recommendations may be associated with better health outcomes although the optimal level is not known. The most advantageous serum concentrations of 25(OH)D of 75nmol/L (30ng/mL) are based on factors such as reduction in fractures rates, maximum suppression of PTH and maximum calcium absorption as well as non skeletal outcomes. An intake of at least 1000 IU is suggested to bring at least 50% of the population up to 75nmol/L
  7. Australian studies have included limited numbers of subjects.
  8. Sunlight 1 MED = 20000 IU Hands, arms, neck (11%) for 20 minutes in summer early am = 1000 IU Salmon 160g fillet approx. 530 IU Fortified cheese slice 55 IU Regular milk 20 IU Margarine 12 IU Multivitamins ave.200 IU Caltrate with D 400 IU Specific D ave. 1000IU
  9. Study Design Explain patient status Define setting Aria; SEIFA. latitude obtained from postcode
  10. Based on visual inspection of vitamin D level by age we classified subjects into age groups: <20; 20-39. 40-59, 60-79, ≥80
  11. Inpatients always lower than ambulatory subjects except females in very remote Australia.
  12. See higher percentage of deficiency and severe deficiency in all age groups for both ambulatory and inpatients Highest percentage of sufficiency in those aged 80 and over
  13. Although it may be a compromise between the negative effects of UVA exposure due to longer durations early and late in the day.
  14. The subjects with serum concentrations of 25-hydroxyvitamin D [25(OH)D] < 40 nmol/L (n = 24) had significantly (P = 0.004) more days of absence from duty due to respiratory infections (median: 4; quartile 1–quartile 3: 2–6) than did controls (2; 0–4; incidence rate ratio: 1.63; 95% CI: 1.15, 2.24; n = 628). The model was adjusted for smoking (n = 169) (Poisson regression analysis).